Tyrosine kinase inhibitor (TKI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tyrosine kinase inhibitor (TKI), covering 2021-10-05 to 2021-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma. [Phase 2]